Telix Pharmaceuticals(@TelixPharma) 's Twitter Profile Photo

Join Telix at in San Antonio!​

Oral presentations will feature TLX591, our lead rADC therapy candidate and Illuccix®, our PSMA-PET agent in prostate cancer.​

Visit booth 631 to discuss our theranostic programs in urology and click here for more: bit.ly/3WnY34q

Join Telix at #AUA2024 in San Antonio!​

Oral presentations will feature TLX591, our lead rADC therapy candidate and Illuccix®, our PSMA-PET agent in prostate cancer.​

Visit booth 631 to discuss our theranostic programs in urology and click here for more: bit.ly/3WnY34q
account_circle